These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16104466)

  • 1. [Influenza vaccination in the elderly population in Mexico: economic considerations].
    Gutiérrez JP; Bertozzi SM
    Salud Publica Mex; 2005; 47(3):234-9. PubMed ID: 16104466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children.
    Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R
    BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
    Chen C; Liu GE; Wang MJ; Gao TF; Jia HP; Yang H; Feng LZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):993-999. PubMed ID: 31607044
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
    Newall AT; Dehollain JP
    Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
    Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
    Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization.
    Mullooly JP; Bennett MD; Hornbrook MC; Barker WH; Williams WW; Patriarca PA; Rhodes PH
    Ann Intern Med; 1994 Dec; 121(12):947-52. PubMed ID: 7978721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
    Yang MC; Tan EC; Su JJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
    Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
    Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of influenza vaccination of older adults in the ED setting.
    Patterson BW; Khare RK; Courtney DM; Lee TA; Kyriacou DN
    Am J Emerg Med; 2012 Sep; 30(7):1072-9. PubMed ID: 21908140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    Wong C; Jiang M; You JH
    PLoS One; 2016; 11(12):e0169030. PubMed ID: 28006012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.